D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 69 Citations 15,217 202 World Ranking 1655 National Ranking 822

Overview

What is she best known for?

The fields of study she is best known for:

  • Antibody
  • Internal medicine
  • Immune system

Her primary areas of investigation include Immunology, Vaccination, Antibody, Streptococcus pneumoniae and Conjugate vaccine. Her Immunology research is multidisciplinary, incorporating perspectives in Pneumococcal conjugate vaccine, Pneumococcal infections and Virology. Helena Käyhty has included themes like Booster dose, Immunization, Immunogenicity, Internal medicine and Pediatrics in her Vaccination study.

Her study in Antibody is interdisciplinary in nature, drawing from both Diphtheria toxin, Serotype, Microbiology and Saliva. Her research integrates issues of Avidity, Pneumonia and Streptococcaceae in her study of Streptococcus pneumoniae. Her Conjugate vaccine research includes elements of Haemophilus influenzae, Antibody titer, Licensure, Diphtheria and Toxoid.

Her most cited work include:

  • Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media (1332 citations)
  • The fundamental link between pneumococcal carriage and disease (388 citations)
  • Reduction of Oropharyngeal Carriage of Haemophilus influenzae Type b (Rib) in Children Immunized with an Rib Conjugate Vaccine (344 citations)

What are the main themes of her work throughout her whole career to date?

Helena Käyhty mostly deals with Immunology, Antibody, Vaccination, Streptococcus pneumoniae and Microbiology. Her Immunology study combines topics from a wide range of disciplines, such as Pneumococcal conjugate vaccine, Haemophilus influenzae and Virology. In her work, Chronic lymphocytic leukemia is strongly intertwined with Serotype, which is a subfield of Antibody.

Her Vaccination study integrates concerns from other disciplines, such as Polysaccharide Vaccine, Immunization, Internal medicine and Pediatrics. Her research in the fields of Pneumococcal infections and Pneumococcal vaccine overlaps with other disciplines such as Carriage. The Microbiology study combines topics in areas such as Pneumolysin, Neisseria meningitidis, Bacterial capsule, Saliva and Immunoglobulin M.

She most often published in these fields:

  • Immunology (73.59%)
  • Antibody (52.38%)
  • Vaccination (41.13%)

What were the highlights of her more recent work (between 2012-2021)?

  • Streptococcus pneumoniae (38.53%)
  • Immunology (73.59%)
  • Vaccination (41.13%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Streptococcus pneumoniae, Immunology, Vaccination, Pneumococcal conjugate vaccine and Antibody. Her Streptococcus pneumoniae study also includes

  • Haemophilus influenzae and Community-acquired pneumonia most often made with reference to Microbiology,
  • Antigen together with Immunoassay. Her study in Immunology is interdisciplinary in nature, drawing from both Nasopharyngeal carriage, Pneumococcal vaccine and Virology.

The various areas that Helena Käyhty examines in her Vaccination study include Immunoglobulin G, Immune system, Pediatrics and Pneumococcal polysaccharide vaccine. Her Pneumococcal conjugate vaccine study incorporates themes from Colonisation, Streptococcus pneumoniae vaccine, Vaccine efficacy, Pneumococcal infections and Conjugate vaccine. In her study, Chronic lymphocytic leukemia is strongly linked to Serotype, which falls under the umbrella field of Antibody.

Between 2012 and 2021, her most popular works were:

  • Colonisation endpoints in Streptococcus pneumoniae vaccine trials (38 citations)
  • Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up. (25 citations)
  • A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens (23 citations)

In her most recent research, the most cited papers focused on:

  • Antibody
  • Immune system
  • Internal medicine

Helena Käyhty mainly investigates Streptococcus pneumoniae, Immunology, Haemophilus influenzae, Microbiology and Pneumonia. Her Streptococcus pneumoniae research focuses on Antigen and how it relates to Serology and Antibody. Her study in the field of Immunoassay is also linked to topics like Multiplex.

Her Immunology research integrates issues from Pneumococcal vaccine and Virology. Her biological study spans a wide range of topics, including Observational study, Immunodeficiency, Serotype, Natural history and Pediatrics. Helena Käyhty works on Immunization which deals in particular with Conjugate vaccine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

Eskola J;Kilpi T;Palmu A;Jokinen J.
The New England Journal of Medicine (2001)

2161 Citations

The fundamental link between pneumococcal carriage and disease

Birgit Simell;Kari Auranen;Helena Käyhty;David Goldblatt.
Expert Review of Vaccines (2012)

629 Citations

Reduction of Oropharyngeal Carriage of Haemophilus influenzae Type b (Rib) in Children Immunized with an Rib Conjugate Vaccine

Aino K. Takala;Juhani Eskola;Maija Leinonen;Helena Kayhty.
The Journal of Infectious Diseases (1991)

530 Citations

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

H Peltola;H Käyhty;M Virtanen;P H Mäkelä.
The New England Journal of Medicine (1984)

465 Citations

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

Heikki Peltola;P. Helena Mäkelä;Helena Käyhty;Hannele Jousimies.
The New England Journal of Medicine (1977)

450 Citations

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

J Eskola;H Käyhty;A K Takala;H Peltola.
The New England Journal of Medicine (1990)

449 Citations

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

Luis Jódar;Jay Butler;George Carlone;Ron Dagan.
Vaccine (2003)

405 Citations

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Catherine M. Wernette;Carl E. Frasch;Dace Madore;George Carlone.
Clinical and Vaccine Immunology (2003)

353 Citations

Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.

J Eskola;H Peltola;A K Takala;H Käyhty.
The New England Journal of Medicine (1987)

347 Citations

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen.
Clinical Infectious Diseases (2003)

332 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Helena Käyhty

Ron Dagan

Ron Dagan

Ben-Gurion University of the Negev

Publications: 117

David Goldblatt

David Goldblatt

University College London

Publications: 106

Shabir A. Madhi

Shabir A. Madhi

University of the Witwatersrand

Publications: 99

Ray Borrow

Ray Borrow

Manchester Royal Infirmary

Publications: 93

Andrew J. Pollard

Andrew J. Pollard

University of Oxford

Publications: 82

Keith P. Klugman

Keith P. Klugman

Bill & Melinda Gates Foundation

Publications: 71

Moon H. Nahm

Moon H. Nahm

University of Alabama at Birmingham

Publications: 65

Elisabeth A. M. Sanders

Elisabeth A. M. Sanders

Utrecht University

Publications: 64

Dan M. Granoff

Dan M. Granoff

UCSF Benioff Children's Hospital

Publications: 61

David E. Briles

David E. Briles

University of Alabama at Birmingham

Publications: 57

William C. Gruber

William C. Gruber

Pfizer (United States)

Publications: 55

George M. Carlone

George M. Carlone

Centers for Disease Control and Prevention

Publications: 53

Katherine L. O’Brien

Katherine L. O’Brien

Johns Hopkins University

Publications: 51

Stephen B. Gordon

Stephen B. Gordon

Liverpool School of Tropical Medicine

Publications: 51

Stephen I. Pelton

Stephen I. Pelton

Boston University

Publications: 51

Brian Greenwood

Brian Greenwood

London School of Hygiene & Tropical Medicine

Publications: 51

Trending Scientists

Sergio Bittanti

Sergio Bittanti

Polytechnic University of Milan

Eric Allender

Eric Allender

Rutgers, The State University of New Jersey

Feng Zhao

Feng Zhao

Microsoft (United States)

Xiaoyan Zeng

Xiaoyan Zeng

Huazhong University of Science and Technology

Kiyoshi Naruse

Kiyoshi Naruse

National Institute for Basic Biology

Rod M. Connolly

Rod M. Connolly

Griffith University

J. G. Sutcliffe

J. G. Sutcliffe

Scripps Research Institute

Marek Grad

Marek Grad

University of Warsaw

Jeffrey L. Marion

Jeffrey L. Marion

United States Geological Survey

Robert S. Kern

Robert S. Kern

University of California, Los Angeles

Jean Lud Cadet

Jean Lud Cadet

National Institute on Drug Abuse

Claus Christiansen

Claus Christiansen

Nordic Bioscience

Jay S. Skyler

Jay S. Skyler

University of Miami

Andrew Sayer

Andrew Sayer

Lancaster University

Benjamin O. Fordham

Benjamin O. Fordham

Binghamton University

Darach Watson

Darach Watson

University of Copenhagen

Something went wrong. Please try again later.